These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The clinical value of KL-6 for predicting the occurrence and severity of connective tissue disease-associated interstitial lung disease is not affected by CTD type or treatment. Xing H; Liang H PeerJ; 2024; 12():e17792. PubMed ID: 39131623 [TBL] [Abstract][Full Text] [Related]
4. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease. Ma H; Lu J; Song Y; Wang H; Yin S BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline. Nagy A; Nagy T; Kolonics-Farkas AM; Eszes N; Vincze K; Barczi E; Tarnoki AD; Tarnoki DL; Nagy G; Kiss E; Maurovich-Horvat P; Bohacs A; Müller V Front Pharmacol; 2021; 12():778649. PubMed ID: 35002713 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience. Boutel M; Boutou A; Pitsiou G; Garyfallos A; Dimitroulas T Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046439 [TBL] [Abstract][Full Text] [Related]
7. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease. Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869 [TBL] [Abstract][Full Text] [Related]
8. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial. Maher TM; Tudor VA; Saunders P; Gibbons MA; Fletcher SV; Denton CP; Hoyles RK; Parfrey H; Renzoni EA; Kokosi M; Wells AU; Ashby D; Szigeti M; Molyneaux PL; Lancet Respir Med; 2023 Jan; 11(1):45-54. PubMed ID: 36375479 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis. Yang M; Wu Y; Liu X; Zhao C; Li T; Li T; Zhang X; Jiang H; Mao B; Liu W Respir Med; 2023 Sep; 216():107329. PubMed ID: 37315742 [TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias. Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371 [TBL] [Abstract][Full Text] [Related]
12. Rituximab for connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis. Wang Y; Li L Int J Rheum Dis; 2023 Feb; 26(2):225-235. PubMed ID: 36378118 [TBL] [Abstract][Full Text] [Related]
13. The Efficacy and Safety of Pirfenidone Combined With Immunosuppressant Therapy in Connective Tissue Disease-Associated Interstitial Lung Disease: A 24-Week Prospective Controlled Cohort Study. Wang J; Wang X; Qi X; Sun Z; Zhang T; Cui Y; Shu Q Front Med (Lausanne); 2022; 9():871861. PubMed ID: 35646960 [TBL] [Abstract][Full Text] [Related]
14. Assessing prognostic factors correlating with response to nintedanib for connective tissue disease-associated interstitial lung disease: A real-world single-center study. Kokubu H; Takeuchi S; Tozawa T; Hisada S; Yamada Y; Itoh Y; Kodera M Int J Rheum Dis; 2023 Apr; 26(4):682-688. PubMed ID: 36808836 [TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease]. Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110 [No Abstract] [Full Text] [Related]
16. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases. Lamb YN Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296 [TBL] [Abstract][Full Text] [Related]